Literature DB >> 1870439

Role of L3T4+ and Lyt-2+ T cell subsets in protective immune responses of mice against infection with a low or high virulent strain of Toxoplasma gondii.

H Nagasawa1, T Manabe, Y Maekawa, M Oka, K Himeno.   

Abstract

In order to elucidate the role of T cell subsets in protective immunity against infection with high virulent and low virulent strains of Toxoplasma gondii, monoclonal antibodies specific for T cell subsets were injected into mice before immunization or challenge infection. Treatment of mice with monoclonal antibody to either L3T4+ or Lyt-2+ T cells before they were immunized with Toxoplasma cell homogenate prepared from high virulent RH strain tachyzoites markedly reduced survival after mice were challenged with low virulent bradyzoites of the Beverley strain. Thus, induction of protective immunity against bradyzoites of the Beverley strain requires the presence of both L3T4+ and Lyt-2+ T cells. In contrast, mice injected with living bradyzoites of the low virulent Beverley strain after immunization with Toxoplasma cell homogenate acquired protective immunity against high virulent tachyzoites of the RH strain. Lyt-2+ T cells alone appear to be final effector cells for protection against the challenge with high virulent RH strain tachyzoites, since treatment of the bradyzoite-immune mice with anti-Lyt-2 antibody, but not anti-L3T4 antibody, before challenge significantly increased mortality.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1870439     DOI: 10.1111/j.1348-0421.1991.tb01550.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  12 in total

Review 1.  Contribution of 65-kDa heat shock protein induced by gamma and delta T cells to protection against Toxoplasma gondii infection.

Authors:  K Himeno; H Hisaeda
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

2.  Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice.

Authors:  Lawrence L Johnson; Peter C Sayles
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  Granule-dependent killing of Toxoplasma gondii by CD8+ T cells.

Authors:  Y Nakano; H Hisaeda; T Sakai; M Zhang; Y Maekawa; T Zhang; M Nishitani; H Ishikawa; K Himeno
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

4.  Contribution of extrathymic gamma delta T cells to the expression of heat-shock protein and to protective immunity in mice infected with Toxoplasma gondii.

Authors:  H Hisaeda; T Sakai; H Nagasawa; H Ishikawa; K Yasutomo; Y Maekawa; K Himeno
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

5.  Induction of heat shock protein closely correlates with protection against Toxoplasma gondii infection.

Authors:  H Nagasawa; M Oka; K Maeda; C Jian-Guo; H Hisaeda; Y Ito; R A Good; K Himeno
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

6.  B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii.

Authors:  P C Sayles; G W Gibson; L L Johnson
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice.

Authors:  Stephen T Smiley; Paula A Lanthier; Kevin N Couper; Frank M Szaba; Jonathan E Boyson; Wangxue Chen; Lawrence L Johnson
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

8.  Resistance to Toxoplasma gondii in mice infected as neonates or exposed in utero.

Authors:  L L Johnson
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  gamma delta T cells play a crucial role in the expression of 65,000 MW heat-shock protein in mice immunized with Toxoplasma antigen.

Authors:  H Nagasawa; H Hisaeda; Y Maekawa; H Fujioka; Y Ito; M Aikawa; K Himeno
Journal:  Immunology       Date:  1994-11       Impact factor: 7.397

10.  SCID mouse models of acute and relapsing chronic Toxoplasma gondii infections.

Authors:  L L Johnson
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.